NASDAQ:EXPO - Exponent Stock Price, News, & Analysis

Get Started

$50.16 -1.94 (-3.72 %)

(As of 11/21/2018 07:16 AM ET)

Previous Close$52.10

Today's Range$49.28 - $51.60

52-Week Range$34.90 - $54.58

Volume515,684 shs

Average Volume261,221 shs

Market Capitalization$2.71 billion

P/E Ratio46.88

Dividend Yield1.00%

Beta0.61

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Management consulting services

Sub-IndustryResearch & Consulting Services

SectorBusiness Services

Current SymbolNASDAQ:EXPO

Previous Symbol

CUSIP30214U10

Webwww.exponent.com

Phone650-326-9400

Debt

Debt-to-Equity RatioN/A

Current Ratio3.82

Quick Ratio3.82

Price-To-Earnings

Trailing P/E Ratio46.88

Forward P/E Ratio37.71

P/E GrowthN/A

Sales & Book Value

Annual Sales$347.80 million

Price / Sales7.50

Cash Flow$1.1954 per share

Price / Cash41.96

Book Value$6.36 per share

Price / Book7.89

Profitability

EPS (Most Recent Fiscal Year)$1.07

Net Income$41.30 million

Net Margins13.98%

Return on Equity20.92%

Return on Assets14.34%

Miscellaneous

Employees1,075

Outstanding Shares52,010,000

Market Cap$2.71 billion

OptionableOptionable

Exponent (NASDAQ:EXPO) Frequently Asked Questions

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Friday, October 19th. Shareholders of record on Friday, December 7th will be given a dividend of $0.13 per share on Friday, December 21st. This represents a $0.52 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, December 6th. View Exponent's Dividend History.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) posted its quarterly earnings results on Thursday, October, 18th. The business services provider reported $0.32 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.29 by $0.03. The business services provider had revenue of $88.71 million for the quarter, compared to the consensus estimate of $88.52 million. Exponent had a net margin of 13.98% and a return on equity of 20.92%. The business's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.27 earnings per share. View Exponent's Earnings History.

When is Exponent's next earnings date?

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Exponent.

What price target have analysts set for EXPO?

3 equities research analysts have issued twelve-month price targets for Exponent's shares. Their predictions range from $24.00 to $56.00. On average, they expect Exponent's share price to reach $40.00 in the next twelve months. This suggests that the stock has a possible downside of 20.3%. View Analyst Price Targets for Exponent.

What is the consensus analysts' recommendation for Exponent?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exponent.

What are Wall Street analysts saying about Exponent stock?

Here are some recent quotes from research analysts about Exponent stock:

1. According to Zacks Investment Research, "Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. " (10/22/2018)
2. Cantor Fitzgerald analysts commented, "Foresi’s Take. Exponent posted strong revenue growth in the mid-teens, driven by a large project and strong performance in a number of other areas as well. The company noted new significant work starting to flow into the Environmental and Health practice, due to public concern about chemicals affecting ecosystems and human health. Management stated that a large project in the Human Factors practice had higher-than-expected revenues (7% of revenues), but may begin to roll off somewhat in 2018, estimating that this project could constitute 4-5% of revenues at the end of 2018. Full-year utilization is expected to decline by 1-1.5% from last year, and EBITDA margins were guided to decline by 50-100bps y/y." (4/20/2018)

Has Exponent been receiving favorable news coverage?

News articles about EXPO stock have trended somewhat negative this week, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Exponent earned a news sentiment score of -1.2 on InfoTrie's scale. They also gave press coverage about the business services provider a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the stock's share price in the next few days.

Who are some of Exponent's key competitors?

Some companies that are related to Exponent include Booz Allen Hamilton (BAH), Genpact (G), FTI Consulting (FCN), RMR Group (RMR), ICF International (ICFI), Huron Consulting Group (HURN), Navigant Consulting (NCI), NIC (EGOV), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), China Internet Nationwide Fncl Srvcs (CIFS), Wilhelmina International (WHLM) and Lightbridge (LTBR).

Who are Exponent's key executives?

Exponent's management team includes the folowing people:

Dr. Paul R. Johnston, Exec. Chairman (Age 64)
Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 49)
Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 52)
Dr. Harri K. Kytomaa, Group VP of Engineering Sciences & Principal Engineer (Age 59)
Dr. Steven J. Murray, Group VP of Mechanics & Materials and Principal Engineer (Age 43)

Who are Exponent's major shareholders?

Exponent's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.39%), Neuberger Berman Group LLC (7.40%), Conestoga Capital Advisors LLC (4.33%), Dimensional Fund Advisors LP (3.31%), Atlanta Capital Management Co. L L C (2.15%) and GW&K Investment Management LLC (2.05%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss and Sally Shepard. View Institutional Ownership Trends for Exponent.

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including DF Dent & Co. Inc., Atlanta Capital Management Co. L L C, Renaissance Technologies LLC, Neuberger Berman Group LLC, Panagora Asset Management Inc., Copeland Capital Management LLC, JPMorgan Chase & Co. and JPMorgan Chase & Co.. Company insiders that have sold Exponent company stock in the last year include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Insider Buying and Selling for Exponent.

Which major investors are buying Exponent stock?

EXPO stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, WINTON GROUP Ltd, BlackRock Inc., Sandler Capital Management, Morgan Stanley, Hillsdale Investment Management Inc., EULAV Asset Management and Nordea Investment Management AB. View Insider Buying and Selling for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $50.16.

How big of a company is Exponent?

Exponent has a market capitalization of $2.71 billion and generates $347.80 million in revenue each year. The business services provider earns $41.30 million in net income (profit) each year or $1.07 on an earnings per share basis. Exponent employs 1,075 workers across the globe.

What is Exponent's official website?

The official website for Exponent is http://www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

MarketBeat Community Rating for Exponent (NASDAQ EXPO)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		184 (Vote Outperform)
Underperform Votes:		181 (Vote Underperform)
Total Votes:		365

MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 11/21/2018 by MarketBeat.com Staff